These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30367158)

  • 1. Soluble receptor for advanced glycation end products as a vasculopathy biomarker in sickle cell disease.
    Safwat NA; Kenny MA
    Pediatr Res; 2018 Dec; 84(6):869-874. PubMed ID: 30367158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
    Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
    Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
    Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
    Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
    Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
    Prasad K
    Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity?
    Sponder M; Campean IA; Emich M; Fritzer-Szekeres M; Litschauer B; Graf S; Dalos D; Strametz-Juranek J
    Heart Vessels; 2018 Aug; 33(8):893-900. PubMed ID: 29368166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fas/FasL ratio as a marker of vasculopathy in children and adolescents with sickle cell disease.
    Adly AA; Ismail EA; Andrawes NG; Mahmoud MM; Eladawy R
    Cytokine; 2016 Mar; 79():52-8. PubMed ID: 26765484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts.
    Mitran CI; Nicolae I; Tampa M; Mitran MI; Caruntu C; Sarbu MI; Ene CD; Matei C; Ionescu AC; Georgescu SR; Popa MI
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
    Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
    Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the receptor for advanced glycation end products as vasculopathy predictor in sickle cell disease.
    Safwat NA; ELkhamisy MM; Abdel-Wahab SEA; Hamza MT; Boshnak NH; Kenny MA
    Pediatr Res; 2021 Jan; 89(1):185-190. PubMed ID: 32544923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
    Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of serum levels of AGEs to soluble form of RAGE is a predictor of endothelial function.
    Kajikawa M; Nakashima A; Fujimura N; Maruhashi T; Iwamoto Y; Iwamoto A; Matsumoto T; Oda N; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Noma K; Takeuchi M; Matsui T; Yamagishi S; Higashi Y
    Diabetes Care; 2015 Jan; 38(1):119-25. PubMed ID: 25336748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
    Farhan SS; Hussain SA
    Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
    Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
    J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.